Why Bausch Health's Market Cap Was Chopped In Half Thursday: 'A Near Worst-Case Scenario'
Shares of global health company Bausch Health Companies Inc (NYSE: BHC) are plunging Thursday after a Delaware federal judge issued an oral order on patents related to the company's Xifaxan drug.
